The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
Open accessAbstract
Recent studies have established a new regulatory axis in the renin-angiotensin system (RAS). In this axis, angiotensin (Ang)-(1-7) is finally produced from Ang I or Ang II by the catalytic activity of angiotensin-converting enzyme 2 (ACE2). Ang-(1-7) shows actions different from those of AT(1) receptor stimulation, such as vasodilatation, natriuresis, anti-proliferation and an increase in the bradykinin-NO (nitric oxide) system. As the catalytic efficiency of ACE2 is approximately 400-fold higher with Ang II as a substrate than with Ang I, this axis is possibly acting as a counter-regulatory system against the ACE/Ang II/AT(1) receptor axis. The signaling pathway of the ACE2-Ang-(1-7) axis has not yet been totally and clearly understood. However, a recent report suggests that the Mas oncogene acts as a receptor for Ang-(1-7). Intracellular signaling through Mas is not clear yet. Several factors such as Akt phosphorylation, protein kinase C activation and mitogen-activated protein (MAP) kinase inhibition seem to be involved in this signaling pathway. Further investigations are needed to clarify the regulation and mechanism of action of ACE2 and Ang-(1-7). However, this second axis through ACE2 and Ang-(1-7) in RAS can be an important target for the therapy of cardiovascular and metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ACE2 on endothelial cells of the arteries, arterioles, and venules of the heart and kidney determines its ability to regulate vascular function and blood pressure, as reviewed previously.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [53]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Marc De Gasparo, B., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,131
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., Silva, A. C. S. E., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer‐Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bäder, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,805
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,250
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
Elliott, W. J., & Meyer, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60108-1 · Cited by 1,016
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Counterregulatory Actions of Angiotensin-(1-7)
Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.535 · Cited by 509
Disruption of the Ang II type 1 receptor promotes longevity in mice
Benigni, A., Corna, D., Zoja, C., Sonzogni, A., Latini, R., Salio, M., Conti, S., Rottoli, D., Longaretti, L., Cassis, P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36703 · Cited by 486
Flagged first, then by citations
Research works printed but not linked: 1
- Santos RA, Ferreira AJ, E Silva AC . Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93: 519–527. · DOI
Cited by
Sorted by citations
Items 101–200 of 296
Angiotensin II-related hypertension and eye diseases
Marín‐García, P. J. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i9.968 · Cited by 37
Angiotensin-(1-7) inhibits vascular calcification in rats
Sui, Y.-B., Chang, J.-R., Chen, W.-J., Zhao, L., Zhang, B., Yu, Y.-R., Tang, C., Yin, X., & Qi, Y. (2013) · Peptides · doi:10.1016/j.peptides.2012.12.023 · Cited by 36
Expression of the Mas receptor is upregulated in skeletal muscle wasting
Morales, M. G., Ábrigo, J., Meneses, C., Cisternas, F., Simón, F., & Cabello‐Verrugio, C. (2014) · Histochemistry and Cell Biology · doi:10.1007/s00418-014-1275-1 · Cited by 36
Xu, X., Cai, Y., & Yu, Y. (2018) · Inflammopharmacology · doi:10.1007/s10787-018-0449-1 · Cited by 36
Corrêa, H. D. L., Neves, R. V. P., Deus, L. A., Maia, B. C. H., Maya, Á. T. D., Tzanno‐Martins, C., Souza, M. K., Silva, J. A. B., Haro, A. S., Costa, F., et al. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113295 · Cited by 41
Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?
Malek, V., & Gaikwad, A. B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.024 · Cited by 35
Xue, F., Yang, J., Cheng, J., Sui, W., Cheng, C., Li, H., Zhang, M., Zhang, J., Xu, X., Ma, J., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14906 · Cited by 35
PKA-mediated effect of MAS receptor in counteracting angiotensin II-stimulated renal Na+-ATPase
Lara, L. S., Vives, D., Correa, J. S., Cardozo, F. P., Marques-Fernandes, M. F., Lopes, A. G., & Caruso‐Neves, C. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.02.005 · Cited by 35
Angiotensin (1–7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs
Tassone, E. J., Sciacqua, A., Andreozzi, F., Presta, I., Perticone, M., Carnevale, D., Casaburo, M., Hribal, M. L., Sesti, G., & Perticone, F. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt065 · Cited by 34
Zhu, Z., Wang, M., Lin, W. S., Cai, Q., Zhang, L., Chen, D., Liu, F., Xiong, X., Chu, J., Peng, J., et al. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.471 · Cited by 32
Inaba, S., Iwai, M., Furuno, M., Kan‐no, H., Senba, I., Okayama, H., Mogi, M., Higaki, J., & Horiuchi, M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834bbb4d · Cited by 32
Self-citationElton, T. S., Sansom, S. E., & Martin, M. M. (2010) · International Journal of Hypertension · doi:10.4061/2010/281692 · Cited by 34
Suski, M., Gębska, A., Olszanecki, R., Stachowicz, A., Uracz, D., Madej, J., & Korbut, R. (2013) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313475907 · Cited by 31
Lange, C., Sommerfeld, M., Namsolleck, P., Kintscher, U., Unger, T., & Kaschina, E. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11168 · Cited by 33
The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis
Moreira, F. R. C., de Oliveira, T. A., Ramos, N. E., Abreu, M. A. D., & Silva, A. C. E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06672-8 · Cited by 25
Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)
Włodarczyk, J., Czerwiński, B., & Fichna, J. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00415-7 · Cited by 34
Zamolodchikova, T. S., Tolpygo, S. M., & Kotov, A. V. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1293221 · Cited by 31
Yamakoshi, S., Nakamura, T., Mori, N., Suda, C., Kohzuki, M., & Ito, O. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002605 · Cited by 30
Khoury, E. E., Knaney, Y., Fokra, A., Kinaneh, S., Azzam, Z. S., Heyman, S. N., & Abassi, Z. A. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16310 · Cited by 28
Olkowicz, M., Chłopicki, S., & Smolenski, R. T. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.03.017 · Cited by 30
Olkowicz, M., Radulska, A., Suraj, J., Kij, A., Walczak, M., Chłopicki, S., & Smolenski, R. T. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.03.012 · Cited by 29
Li, Y., Wang, Y., Lu, C., & Li, X. (2013) · Journal of Diabetes Research · doi:10.1155/2013/405284 · Cited by 28
Li, G., Xu, Y., Ling, F., Liu, A., Wang, D., Wang, Q., & Liu, Y. (2012) · PubMed · Cited by 27
The renin-angiotensin-aldosterone system: An old tree sprouts new shoots
Ruan, Y., Yu, Y., Wu, M., Jiang, Y., Qiu, Y., & Ruan, S. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111426 · Cited by 26
Wang, L., & Leung, P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.008 · Cited by 23
Smith, J. A., Pati, D., Wang, L. A., de Kloet, A. D., Frazier, C. J., & Krause, E. G. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00046 · Cited by 25
Wang, Y., Xu, H., Fu, W., Lu, Z., Guo, M., Wu, X., Sun, M., Liu, Y., Yu, X., & Sui, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00475 · Cited by 25
Ibarra-Lara, L., Cervantes-Pérez, L. G., Pérez‐Severiano, F., del Valle‐Mondragón, L., Rubio-Ruiz, M. E., Soria‐Castro, E., Pastelín-Hernández, G. S., Sánchez-Aguilar, M., Martínez‐Lazcano, J. C., & Sánchez-Mendoza, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.039 · Cited by 25
Kong, E., Zhang, J., An, N., Tao, Y. K., Yu, W., & Wu, F. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0466-2 · Cited by 24
Xu, X., Shi, L., Ma, X., Su, H., Ma, G., Wu, X., Ying, K., & Zhang, R. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.02.016 · Cited by 24
Tiwari, V., Singh, J., Tiwari, P., Chaturvedi, S., Gupta, S., Mishra, A., Singh, S., Wahajuddin, M., Hanif, K., & Shukla, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175623 · Cited by 25
Ruchaya, P. J., Speretta, G. F. F., Blanch, G. T., Li, H., Sumners, C., Menani, J. V., Colombari, E., & Colombari, D. S. A. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.06.006 · Cited by 24
Prehypertension: Underlying pathology and therapeutic options
Albarwani, S. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i8.728 · Cited by 24
Sainsily, X., Coquerel, D., Giguère, H., Dumont, L., Trân, K., Noll, C., Ionescu, A. L., Côté, J., Longpré, J., Carpentier, A. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709467 · Cited by 23
Effect of ArtemiC in patients with COVID‐19: A Phase II prospective study
Hellou, E., Mohsin, J., Elemy, A., Hakim, F., Hellou, M. M., & Hamoud, S. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17337 · Cited by 22
Angiotensin-(1–7) Modulates Angiotensin II-Induced Vasoconstriction in Human Mammary Artery
Mendonça, L., Mendes‐Ferreira, P., Bento-Leite, A., Cerqueira, R. J., Amorim, M. J., Pinho, P., Brás‐Silva, C., Leite-Moreira, A. F., & Castro‐Chaves, P. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6555-4 · Cited by 23
Mohite, S., Sanches, M., & Teixeira, A. L. (2019) · Protein and Peptide Letters · doi:10.2174/0929866527666191223144000 · Cited by 25
Li, N., Cai, R., NIU, Y., Shen, B., Xu, J., & Cheng, Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1080 · Cited by 23
Wang, H.-J., Chen, S., & Lo, W. (2016) · Scientific Reports · doi:10.1038/srep35372 · Cited by 22
Simultaneous inhibition of neprilysin and activation of ACE2 prevented diabetic cardiomyopathy
Malek, V., Sharma, N., & Gaikwad, A. B. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.008 · Cited by 22
Mi, X., Cao, Y., Li, Y., Li, Y., Hong, J., He, J., Liang, Y., Yang, N., Liu, T., Han, D., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.624387 · Cited by 22
Hypoxia induces dysregulation of local renin-angiotensin system in mouse Lewis lung carcinoma cells
Fan, L., Feng, Y., Wan, H., Ni, L., Qian, Y., Guo, Y., Xiang, Y., & Li, Q. Y. (2014) · Genetics and Molecular Research · doi:10.4238/2014.december.12.19 · Cited by 22
Pernomian, L., Gomes, M. S., Restini, C. B. A., & de Oliveira, A. M. (2014) · BioMed Research International · doi:10.1155/2014/640329 · Cited by 21
Ono, T., Sanai, T., Miyahara, Y., & Noda, R. (2013) · Current Therapeutic Research · doi:10.1016/j.curtheres.2013.02.002 · Cited by 20
The Therapeutic Role of Renin-Angiotensin System Blockers in Obesity- Related Renal Disorders
Santos, S. H. S., & Silva, A. C. S. E. (2014) · Current Clinical Pharmacology · doi:10.2174/15748847112079990050 · Cited by 21
Snouwaert, J. N., Jania, L. A., Nguyen, T. T. H., Martinez, D. R., Schäfer, A., Catanzaro, N., Gully, K. L., Baric, R. S., Heise, M. T., Ferris, M. T., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011168 · Cited by 22
El‐Mahdy, N. A., El‐Sayad, M. E., & El-Kadem, A. H. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.001 · Cited by 20
Danish Nationwide Data Reveal a Link between Diabetes Mellitus, Diabetic Retinopathy, and Glaucoma
Horwitz, A., Petrovski, B. É., Torp-Pedersen, C. T., & Kolko, M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2684674 · Cited by 20
Bernstein, K. E., Cao, D., Shibata, T., Saito, S., Bernstein, E. A., Nishi, E., Yamashita, M., Tourtellotte, W. G., Zhao, T. V., & Khan, Z. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107388 · Cited by 20
Overview of the renin-angiotensin system in diabetic nephropathy
Karimi, F., Maleki, M., Movahedpour, A., Alizadeh, M., Kharazinejad, E., & Sabaghan, M. (2024) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203241302966 · Cited by 19
Zhang, Y., Jia, L., Zhang, Y., Ji, W., & Li, H. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000486919 · Cited by 19
Gul, R., Ramdas, M., Mandavia, C. H., Sowers, J. R., & Pulakat, L. (2012) · Cardiorenal Medicine · doi:10.1159/000343456 · Cited by 17
Assessment and Management of Diabetic Patients During the COVID-19 Pandemic
Verma, A. K., Beg, M. M. A., Bhatt, D., Dev, K., Alsahli, M. A., Rahmani, A. H., & Goyal, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s285614 · Cited by 19
Montori-Grau, M., Tarrats, N., Osorio-Conles, Ó., Orozco, A., Serrano, L., Vázquez‐Carrera, M., & Gómez-Foix, A. M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.02.014 · Cited by 16
Aimo, A., Vergaro, G., Passino, C., & Clerico, A. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2021.1942782 · Cited by 17
Leung, P. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9060-7_5 · Cited by 17
Lin, S., Pan, H., Wu, H., Ren, D., & Lu, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7168 · Cited by 16
New perspectives on angiotensin-converting enzyme 2 and its related diseases
Liu, L.-P., Zhang, X., & Li, J. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.839 · Cited by 15
Toyama, T., Sato, C., Koyama, K., Kasama, S., Murakami, J., Yamashita, E., Kawaguchi, R., Adachi, H., Hoshizaki, H., & Oshima, S. (2012) · Cardiology · doi:10.1159/000339762 · Cited by 15
Direct Renin Inhibition in a Rat Model of Chronic Allograft Injury
Rusai, K., Schmaderer, C., Hermans, J. J. R., Lutz, J., Heemann, U. W., & Baumann, M. (2011) · Transplantation · doi:10.1097/tp.0b013e318230c05b · Cited by 15
The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19
Alexandrova, R., Beykov, P., Vassilev, D. I., Jukič, M., & Podlipnik, Č. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2020.1847683 · Cited by 16
Zou, X., Zhang, X., Liu, X., Li, R., Wang, M., Wu, W., Sui, Y., & Zhao, H. (2015) · Journal of Diabetes Research · doi:10.1155/2015/310645 · Cited by 15
Siafi, E. P., Andrikou, I., Thomopoulos, C., Konstantinidis, D., Kakouri, N., Tatakis, F., Kariori, M. G., Filippou, C. D., Zamanis, I., Manta, E., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-01015-x · Cited by 14
Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum
Pop, D., Dădârlat‐Pop, A., Tomoaia, R., Zdrenghea, D. T., & Caloian, B. (2024) · Biomedicines · doi:10.3390/biomedicines12071582 · Cited by 14
Bobrovskaya, L., Maniam, J., Ong, L. K., Dunkley, P. R., & Morris, M. J. (2013) · Neurochemical Research · doi:10.1007/s11064-013-0985-4 · Cited by 14
Zhou, J., Wang, Y., Li, S. Q., Zhang, J. Q., Lin, Y. N., Sun, X. W., Zhou, L. N., Zhang, L., Lu, F. Y., Ding, Y. J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01662-0 · Cited by 13
Highly expressed ACE-2 receptors during pregnancy: A protective factor for SARS-COV-2 infection?
Figueiró-Filho, E. A., Hobson, S. R., Farine, D., & Yudin, M. H. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110641 · Cited by 13
Bai, X., Zhao, J., Shi, S., Zhu, C., & Wang, Y. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14734 · Cited by 13
Ehrig, J., Horvat, D., Allen, S. R., Jones, R. O., Kuehl, T. J., & Uddin, M. N. (2014) · Placenta · doi:10.1016/j.placenta.2014.07.014 · Cited by 13
Castelo‐Branco, R. C., Dellova, D. C. A. L., Fernandes, F. B., Malnic, G., & de Mello-Aires, M. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00557.2016 · Cited by 13
Chen, I.-C., Lin, J., Liu, Y., Chai, C., Yeh, J., Hsu, J., Wu, B., & Dai, Z. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.48096 · Cited by 13
Balakumar, P., Handa, S., Alqahtani, A., Alqahtani, T., Khan, N. A., Lakshmiraj, R. S., Thangathirupathi, A., Sundram, K., & Shenoy, V. (2022) · Cardiovascular Toxicology · doi:10.1007/s12012-022-09724-y · Cited by 12
Drugs Targeting RAAS in the Treatment of Hypertension and Other Cardiovascular Diseases
Balakumar, P., & Jagadeesh, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_36 · Cited by 12
Sankhe, R., Kinra, M., Mudgal, J., Arora, D. S., & Nampoothiri, M. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1669246 · Cited by 12
Novel Strategies and Targets for the Management of Hypertension
TAYLOR, D. A. H. B., & Abdel‐Rahman, A. A. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57008-6 · Cited by 12
Pharmacological Potential of Exercise and RAS Vasoactive Peptides for Prevention of Diseases
Petriz, B. A., de Almeida, J. A., Migliolo, L., & Franco, O. L. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990063 · Cited by 12
Saberi, S., Dehghani, A., & Nematbakhsh, M. (2016) · Europe PMC (PubMed Central) · Cited by 12
Wang, K., Xu, Y., Yang, W., & Zhang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.15666 · Cited by 12
Hoevenaar, M., Goossens, D., & Roorda, J. (2020) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320320979097 · Cited by 12
Koch, A., Kähler, W., Klapa, S., Grams, B., & van Ooij, P.-J. A. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-00323-1 · Cited by 11
Role of Chrononutrition in the Antihypertensive Effects of Natural Bioactive Compounds
Ibarz-Blanch, N., Morales, D., Calvo, E., Ros-Medina, L., Muguerza, B., Bravo, F. I., & Suárez, M. (2022) · Nutrients · doi:10.3390/nu14091920 · Cited by 13
Dehghani, A., Saberi, S., & Nematbakhsh, M. (2015) · Advances in Pharmacological Sciences · doi:10.1155/2015/801053 · Cited by 11
Morosan, P. A., Bobu, A. M., Cărăuleanu, A., Popa, R. F., Costea, C. F., Filip, C., Buzdugă, C. M., Pătrășcanu, E., Cucu, A. I., Tudosa, R. I., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110717 · Cited by 15
Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19
Zhao, F., Zhang, K., Chen, H., Zhang, T., Zhao, J., Lv, Q., Yu, Q., Ruan, M., Cui, R., & Li, B. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01380-0 · Cited by 11
Towards precision management of cardiovascular patients with COVID-19 to reduce mortality
Zhou, K., Yang, S., & Jia, P. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.04.012 · Cited by 9
Fan, Z., Kitaura, H., Ren, J., Ohori, F., Noguchi, T., Marahleh, A., Ma, J., Kanou, K., Miura, M., Narita, K., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1207502 · Cited by 9
Chen, Q., Liu, R., Wei, C., Wang, X., Wu, X., Fan, R., Yu, X., Li, Z., Mao, R., Hu, J., et al. (2023) · Nutrients · doi:10.3390/nu15245130 · Cited by 9
Pernomian, L., Pernomian, L., Gomes, M. D. S., & da Silva, C. H. T. P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.009 · Cited by 9
Huang, H., Zhou, J., Cui, Z., Wang, B., & Hu, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3849 · Cited by 9
Chen, S., Wang, L.-Y., Liaw, M., Wu, M., Wu, P., Wei, C., Chen, A.-N., Su, T.-L., Chang, J., Yang, T., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.763217 · Cited by 9
Nodular glomerulosclerosis and renin angiotensin system in Chinese patients with type 2 diabetes
Wang, M., Zhang, X., Song, X.-N., Zou, X., Wu, W., Wang, Y., Lin, B., Li, R., Hu, F., & Zhao, H. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.03.008 · Cited by 9
Miloradović, Z., Ivanov, M., Jovović, Đ., Karanović, D., Vajić, U.-J., Markovic‐Lipkovski, J., Mihailovic‐Stanojevic, N., & Grujić-Milanović, J. D. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0514-4 · Cited by 9
Qoms, M. S., Wong, S. K., Fauzi, N. M., Husain, K., Makpol, S., & Tan, J. K. (2025) · Antioxidants · doi:10.3390/antiox14101170 · Cited by 8
Siafi, E., Andrikou, I., Konstantinidis, D., Kakouri, N., Iliakis, P., Koskinas, J., Koullias, E., Thireos, E., Tousoulis, D., Thomopoulos, C., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002954 · Cited by 8
ACE Inhibitors and Sarcopenia: Covering All the BASEs?
Springer, J., & von Haehling, S. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0417-7 · Cited by 8
Mata‐Greenwood, E., Blood, A. B., Sands, L. D., Bragg, S. L., Xiao, D., & Zhang, L. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00289.2017 · Cited by 7
The role of renin-angiotensin system activated phagocytes in the SARS-CoV-2 coronavirus infection
Göbölös, L., Rácz, I., Hogan, M. P., Remsey-Semmelweis, E., Atallah, B., Almahmeed, W. A., Alsindi, F., Suri, R. M., Bhatnagar, G., & Tuzcu, E. M. (2020) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.12.056 · Cited by 7
Xu, C., Chen, Y., & Yu, J. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2021002 · Cited by 7
Vašků, A., Vašků, J. B., Pařenica, J., Goldbergová, M. P., Lipková, J., Zlámal, F., Kala, P., & Špinar, J. (2012) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320312460291 · Cited by 7
Vianello, A., Guarnieri, G., Braccioni, F., Molena, B., Lococo, S., Achille, A., Lionello, F., Salviati, L., Caminati, M., & Senna, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194493 · Cited by 7
Metadata
- Authors
- Iwai, M., & Horiuchi, M.
- Affiliations
- Ehime University (JP)
- Corresponding author
- Horiuchi, Masatsugu
- Venue
- Hypertension Research
- Published
- 2009-05-22
- Volume
- 32
- Issue
- 7
- Pages
- 533-536
- ISSN
- 0916-9636 (ISSN-L)
- 1348-4214
- PMC
- PMC7091931
- OpenAlex
- W2067142583
- Cited by
- 296
- References
- 37
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 11 · 2023: 20 · 2022: 21 · 2021: 29 · 2020: 29 · 2019: 12 · 2018: 14 · 2017: 10 · 2016: 17 · 2015: 27 · 2014: 19 · 2013: 19 · 2012: 23
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Hypertension Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- renin-angiotensin system, angiotensin-(1-7), angiotensin-converting enzyme 2, Mas receptor, angiotensin II type 1 receptor, angiotensin II, vasodilation, sodium excretion, Akt phosphorylation, protein kinase C, MAP kinase inhibition, cardiovascular disease treatment
- MeSH terms
- Angiotensin-Converting Enzyme 2, Proto-Oncogene Mas, Angiotensin I, Animals, Humans, Peptidyl-Dipeptidase A, Peptide Fragments, Proto-Oncogene Proteins, Renin-Angiotensin System, Signal Transduction, Receptors, G-Protein-Coupled, Receptor, Angiotensin, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review